CD4 and cancer: It can be found that IGFL2 was correlated with most immune cells, B cells, CD4+ T cells, CD8+ T cells, macrophages, neutrophils, and Myeloid dendritic cell were correlated with 9, 7, 13, 12, 15, and 24 cancers, respectively.